Jennifer Wilson+FollowHIV Breakthrough: Shot Approved!Major news: the FDA just approved a twice-a-year injection called Yeztugo that’s being called the “closest thing” to an HIV vaccine. It’s shown a wild 99.9% prevention rate in trials—no daily pills needed! The catch? Each shot costs over $14k, even though it could be made for way less. Experts are pushing for a price drop so everyone can actually access this game-changer. Imagine: we could finally end HIV, if it’s made affordable! #HIVPrevention #MedicalBreakthrough #FDAApproval #Health #BodyHealth14235Share
Michael Austin+FollowCancer Drug Approval Sends Stock BuzzingHeads up, stock-watchers: UroGen just got the green light from the FDA for its new bladder cancer treatment, and the stock popped 9% right after. Instead of surgery, patients can now get a weekly treatment—way less hassle. Wall Street’s suddenly super optimistic, with some calling for the stock to nearly triple. The big twist? The FDA said yes even after a panel said no, showing they’ll bend the rules for much-needed meds. Retail investors are hyped, and chatter’s heating up! #StockMarket #FDAApproval #CancerTreatment #Business #Market31815Share
Michelle Welch+FollowNew Hope for Rare Lung CancerBig news for anyone following cancer breakthroughs: the FDA just approved IBTROZI, a next-gen oral drug for advanced ROS1-positive non-small cell lung cancer. This rare type mostly hits younger, non-smokers and often spreads to the brain. IBTROZI showed super high response rates—even for those with brain metastases—and is generally well tolerated. With this approval, patients finally have a promising new option that could really change the game! #LungCancer #FDAApproval #CancerResearch #Health #BodyHealth50Share
wilsonjames+FollowNew Lung Cancer Pill Gets FDA Green LightBig news for lung cancer treatment! The FDA just approved Nuvation Bio’s new once-a-day pill, Ibtrozi, for people with ROS1-positive non-small cell lung cancer. This is a rare type, but the new drug could be a game-changer for those who need more options. Love seeing progress like this in cancer care! #LungCancer #FDAApproval #CancerResearch #Health #BodyHealth513Share
Nicholas Coleman+FollowWeekly Weight Loss Shot Gets FDA Green LightHeads up if you’re on a weight loss journey: there’s a new player in town! The FDA just approved Eli Lilly’s Zepbound, a once-a-week shot for folks looking to shed pounds, especially if you’ve got other health issues in the mix. This isn’t a magic fix—you’ll still need to watch what you eat and move more—but it could make those healthy habits pay off faster. The big shift? More choices for people who want medical help losing weight, not just diet and gym plans. #WeightLoss #HealthNews #FDAApproval #Business126Share
Vincent Perry+FollowNew Sleep Apnea Fix? Zepbound Gets the NodIf you or someone you know snores like a freight train, there’s a new option: Zepbound, a weekly shot, just got FDA approval for treating sleep apnea in adults with obesity. In trials, it helped folks breathe easier at night—literally. But heads up: you can’t mix it with similar meds, and there are some side effects to watch for. Still, it could mean fewer sleepless nights (and less couch napping at work). #SleepApnea #HealthHacks #Zepbound #FDAApproval #Wellness #Business234Share
Allison Bauer+FollowNovavax’s Big FDA Win Sends Shares SoaringNovavax just got its COVID shot fully approved by the FDA, making it the only non-mRNA option in the US—and investors are loving it. The stock popped over 20%! This is a huge move, especially with vaccine access in the spotlight lately. Meanwhile, solar stocks are taking a hit as lawmakers threaten to cut clean energy tax credits, and China’s not happy about new US chip restrictions. Wild day in the markets! #Novavax #FDAApproval #StockMarket #CovidVaccine #SolarStocks #Health00Share
Barry Miller+FollowNovavax’s Big FDA Win Sends Stock SoaringNovavax just got the green light from the FDA for its new protein-based COVID-19 shot, Nuvaxovid, and their stock shot up 25%! This vaccine is aimed at older adults and people with health conditions, and it’s different from the usual mRNA shots. Plus, Sanofi is teaming up with them and dropping $175 million on the deal, with more royalties on the way. Looks like Novavax is back in the game! #Novavax #COVID19 #VaccineNews #StockMarket #FDAApproval #Health01Share
Stacy Fisher+FollowNovavax Vax Finally Gets FDA Green LightAfter weeks of waiting, Novavax’s Covid-19 vaccine just got FDA approval—but only for people 65+ or anyone 12+ with a health condition that puts them at higher risk. Unlike Pfizer and Moderna’s mRNA shots, Novavax uses a more old-school protein-based tech. The FDA wants more studies on rare heart inflammation risks, but experts say the benefits still outweigh the risks for those who need it most. Looks like there’s a new option for high-risk folks this season! #Novavax #Covid19Vaccine #FDAApproval #HealthNews #VaccineUpdate #Health21Share
Jacqueline Howard DDS+FollowNew Hope for Tough Lung Cancer CasesBig news for anyone following cancer breakthroughs: the FDA just approved Emrelis, a new treatment for hard-to-treat lung cancer that targets tumors with too much c-Met protein. It’s a game-changer for folks whose cancer didn’t budge with standard therapies. Bonus: there’s a new test to see if you qualify. Early trial results look promising, but more studies are on the way. Heads up—there are some side effects, so talk to your doc if you’re interested! #LungCancer #FDAApproval #CancerResearch #HealthNews #Health784Share
